Regulation & safety

Compounding pharmacies and peptides sit in genuinely murky regulatory territory in Australia. Here's what the TGA's enforcement position actually means.

Peptides in Australia sit across multiple TGA schedules — and supplying unapproved ones is illegal. Here's how the scheduling system actually works.

Peptide importation in Australia is tightly controlled. Here's what the TGA's rules actually say — and why "research use" labelling doesn't protect you.

Supplying unapproved peptides in Australia carries serious criminal penalties. Here's what the TGA's enforcement framework actually looks like.

The "research use only" label on peptide vials looks like a legal shield, but under TGA law it isn't. Here is what the label actually means in Australia.

Unapproved peptide products circulate widely in Australia, but supplying them without TGA approval is illegal. Here's what the regulatory landscape actually looks like.

How the Special Access Scheme applies to peptides in Australia, what Categories A, B and C allow, and why TGA enforcement around unapproved products is real.

The TGA has ramped up enforcement against unapproved peptides in Australia. Here's what the crackdown means, why it matters, and where the law sits.

Online peptide sales in Australia usually involve unapproved therapeutic goods. Here is how the TGA framework and Therapeutic Goods Act 1989 treat them.